To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:9 Issue:8 Number:12 ISSN#:2564-2537
ACE Report #8389
Ace Report Cover Tumour

Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma

How to Cite

OrthoEvidence. Ifosfamide-based chemotherapy yields high survival rate for treatment of osteosarcoma. ACE Report. 2020;9(8):12. Available from:

Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis

Drug Des Devel Ther. 2015 Nov 4;9:5925-32

Contributing Authors:
XL Fan GP Cai LL Zhu GM Ding

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seven randomized controlled trials with 2,529 patients with histologically confirmed osteosarcoma were included in this meta-analysis. The purpose of this study was to compare the safety and efficacy of ifosfamide-based chemotherapy to a control group receiving chemotherapy without ifosfamide. The results displayed that ifosfamide-based chemotherapy had significantly higher event-free survival, ov...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.